Dubinett SM - Search Results

1

Inhibition of Granulocytic Myeloid-Derived Suppressor Cells Overcomes Resistance to Immune Checkpoint Inhibition in LKB1-Deficient Non-Small Cell Lung Cancer.

Li R, Salehi-Rad R, Crosson W, Momcilovic M, Lim RJ, Ong SL, Huang ZL, Zhang T, Abascal J, Dumitras C, Jing Z, Park SJ, Krysan K, Shackelford DB, Tran LM, Liu B, Dubinett SM. Li R, et al. Among authors: dubinett sm. Cancer Res. 2021 Jun 15;81(12):3295-3308. doi: 10.1158/0008-5472.CAN-20-3564. Epub 2021 Apr 14. Cancer Res. 2021. PMID: 33853830 Free PMC article.

2

Genetic modification of a murine fibrosarcoma to produce interleukin 7 stimulates host cell infiltration and tumor immunity.

McBride WH, Thacker JD, Comora S, Economou JS, Kelley D, Hogge D, Dubinett SM, Dougherty GJ. McBride WH, et al. Among authors: dubinett sm. Cancer Res. 1992 Jul 15;52(14):3931-7. Cancer Res. 1992. PMID: 1617669

3

Human non-small cell lung cancer cells express a type 2 cytokine pattern.

Huang M, Wang J, Lee P, Sharma S, Mao JT, Meissner H, Uyemura K, Modlin R, Wollman J, Dubinett SM. Huang M, et al. Among authors: dubinett sm. Cancer Res. 1995 Sep 1;55(17):3847-53. Cancer Res. 1995. PMID: 7641203

4

Cytokine immunotherapy of non-small cell lung cancer.

Dubinett SM, Kradin RL. Dubinett SM, et al. Reg Immunol. 1993 May-Aug;5(3-4):232-43. Reg Immunol. 1993. PMID: 8240940 Review. No abstract available.

5

Interleukin-8 inhibits non-small cell lung cancer proliferation: a possible role for regulation of tumor growth by autocrine and paracrine pathways.

Wang J, Huang M, Lee P, Komanduri K, Sharma S, Chen G, Dubinett SM. Wang J, et al. Among authors: dubinett sm. J Interferon Cytokine Res. 1996 Jan;16(1):53-60. doi: 10.1089/jir.1996.16.53. J Interferon Cytokine Res. 1996. PMID: 8640452

6

Interleukin-7 gene transfer in non-small-cell lung cancer decreases tumor proliferation, modifies cell surface molecule expression, and enhances antitumor reactivity.

Sharma S, Wang J, Huang M, Paul RW, Lee P, McBride WH, Economou JS, Roth MD, Kiertscher SM, Dubinett SM. Sharma S, et al. Among authors: dubinett sm. Cancer Gene Ther. 1996 Sep-Oct;3(5):302-13. Cancer Gene Ther. 1996. PMID: 8894249

7

Non-small cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production.

Huang M, Sharma S, Mao JT, Dubinett SM. Huang M, et al. Among authors: dubinett sm. J Immunol. 1996 Dec 15;157(12):5512-20. J Immunol. 1996. PMID: 8955201

8

Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production.

Huang M, Stolina M, Sharma S, Mao JT, Zhu L, Miller PW, Wollman J, Herschman H, Dubinett SM. Huang M, et al. Among authors: dubinett sm. Cancer Res. 1998 Mar 15;58(6):1208-16. Cancer Res. 1998. PMID: 9515807

9

Dendritic cells augment granulocyte-macrophage colony-stimulating factor (GM-CSF)/herpes simplex virus thymidine kinase-mediated gene therapy of lung cancer.

Miller PW, Sharma S, Stolina M, Chen K, Zhu L, Paul RW, Dubinett SM. Miller PW, et al. Among authors: dubinett sm. Cancer Gene Ther. 1998 Nov-Dec;5(6):380-9. Cancer Gene Ther. 1998. PMID: 9917093

10

Non-small cell lung cancer cyclooxygenase-2-dependent invasion is mediated by CD44.

Dohadwala M, Luo J, Zhu L, Lin Y, Dougherty GJ, Sharma S, Huang M, Pold M, Batra RK, Dubinett SM. Dohadwala M, et al. Among authors: dubinett sm. J Biol Chem. 2001 Jun 15;276(24):20809-12. doi: 10.1074/jbc.C100140200. Epub 2001 Apr 24. J Biol Chem. 2001. PMID: 11320076 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

253 results

Search Page